Oxidized phospholipids as a new landmark in atherosclerosis.
Itabe
H
H
Department of Microbiology and Molecular Pathology, Faculty of Pharmaceutical Sciences, Teikyo University, Kanagawa, Japan. h-itabe@pharm.teikyo-u.ac.jp
D000911:Antibodies, Monoclonal; D001161:Arteriosclerosis / Q000209:etiology*; D015415:Biomarkers; D006801:Humans; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000276:immunology / Q000378:metabolism*; D010972:Platelet Activating Factor / Q000378:metabolism; D011973:Receptors, LDL / Q000378:metabolism
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D008077:Lipoproteins, LDL; D010713:Phosphatidylcholines; D010972:Platelet Activating Factor; D011973:Receptors, LDL